A new drug called amycretin is stepping into the spotlight, boasting impressive results that have both researchers and those struggling with obesity sitting up and taking notice.

A daily weight loss pill from Novo Nordisk was shown to lower body weight by up to 13% after three months in a Phase 1 clinical trial, according to new findings.

A new weight loss pill called amycretin has helped people lose up to 13% of their body weight in just three months, according to a recent study presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Madrid,

There are so many over-the-counter weight loss supplements in the market Here are some chosen best OTC weight loss pills

Ozempic maker Novo Nordisk has developed a pill that can cause weight loss of up to 13% in three months, according to new trial results. Amycretin is unusual because it mimics the appetite-suppressing hormone GLP-1, like Ozempic but also amylin, a hormone that makes people feel full andhelps control blood sugar.

Discover Action Bronson’s weight loss approach and how he physically transformed himself within 9 months. From workout regime to diet plan, get to it know all!

Some users saw a 13% weight loss in three months.

The new pill, amycretin, mimics the weight-loss capabilities of Ozempic but is delivered in a pill rather than an injection. | ITV National News